Study guide
6.3 ABCD Methods of Clinical Nutrition Assessment
Nutritionist-Dietitian Licensure Examination NDLE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Licensure Law, Ethics, and the Clinical Nutritionist-Dietitian
1.1 NDLE Format, Scoring Rules, and RA 10862 Licensure Requirements 1.2 Scope of Practice, Professional Ethics, and Discipline under RA 10862 1.3 Role of the Clinical Nutritionist-Dietitian, Diet Orders, and Standard Hospital Diets
2 Chapter 2: Anatomy and Physiology for Nutrition I
2.1 Cells, Tissues, Membranes, and the Immune and Lymphatic Systems 2.2 The Digestive System: Organs, Enzymes, GI Hormones, and the Liver 2.3 Endocrine and Nervous System Regulation of Metabolism and Appetite
3 Chapter 3: Anatomy and Physiology II, Energy, and Carbohydrate Metabolism
3.1 Cardiovascular, Respiratory, Renal, Musculoskeletal, and Reproductive Systems 3.2 Energy Metabolism and Energy Expenditure Calculations 3.3 Carbohydrate Chemistry, Digestion, and Glycemic Pathways
4 Chapter 4: Protein, Lipid, Mineral, and Fluid Biochemistry
4.1 Protein Chemistry, Amino Acid Metabolism, and Nitrogen Balance 4.2 Lipid Metabolism, Lipoproteins, and Cardiovascular Biomarkers 4.3 Minerals, Water, Electrolytes, and Acid-Base Balance
5 Chapter 5: Basic Nutrition: Vitamins, Minerals, and the PDRI
5.1 Vitamin Biochemistry: Coenzyme Functions and Deficiency Syndromes 5.2 Vitamins and Minerals: PDRI Values, Food Sources, Bioavailability, Stability, and Toxicity 5.3 Philippine Dietary Reference Intakes (PDRI 2015), Pinggang Pinoy, and Dietary Guidelines
6 Chapter 6: Diet Computation and Clinical Nutrition Assessment
6.1 Food Exchange Lists, Meal Plan Computation, Food Labels, and Nutrient Density 6.2 Computing Desirable Body Weight, Total Energy Requirement, and the Diet Prescription 6.3 ABCD Methods of Clinical Nutrition Assessment
7 Chapter 7: Nutrition Diagnosis, Life-Stage Assessment, and Laboratory Data
7.1 Nutrition Diagnosis, PES Statements, and Medical Record Documentation 7.2 Pediatric, Obstetric, and Geriatric Clinical Nutritional Assessment 7.3 Interpreting Biochemical and Laboratory Data in Nutrition Assessment
8 Chapter 8: Drug-Nutrient Interactions, Diabetes, and Weight Disorders
8.1 Drug-Nutrient Interactions and Nutrient Depletion 8.2 MNT for Diabetes Mellitus and Endocrine Disorders 8.3 MNT for Overweight, Obesity, and Underweight
9 Chapter 9: MNT for Cardiovascular, Renal, and Gastrointestinal Disease
9.1 MNT for Cardiovascular Disease, Hypertension, and Dyslipidemia 9.2 MNT for Renal Diseases (AKI, CKD Stages 1-5, Dialysis, and Nephrotic Syndrome) 9.3 MNT for Disorders of the Gastrointestinal Tract
10 Chapter 10: MNT for Liver, Infectious, Respiratory, Allergic, and Neurologic Conditions
10.1 MNT for Liver, Gallbladder, and Pancreatic Disorders 10.2 MNT for Fevers, Infections, Diarrheal Disease, and Respiratory Disorders 10.3 MNT for Food Allergy and Intolerance, Skin, Rheumatic, Musculoskeletal, and Neurologic Disorders
11 Chapter 11: Critical Illness, Oncology, HIV, and Protein-Energy Malnutrition
11.1 MNT in Critical Illness, Sepsis, Trauma, and Burns 11.2 MNT in Oncology: Cancer Cachexia and Treatment Side Effects 11.3 MNT for HIV/AIDS and for Protein-Energy Malnutrition in Children and Adults
12 Chapter 12: Metabolic Disorders, Dysphagia, and Enteral Nutrition
12.1 MNT for Inborn Errors of Metabolism and Eating Disorders 12.2 Dysphagia, IDDSI Texture-Modified Diets, and Adaptive Feeding 12.3 Enteral Nutrition: Indications, Formula Selection, Access Routes, and Complications
13 Chapter 13: Parenteral Nutrition, Refeeding, and Nutrition Counseling
13.1 Parenteral Nutrition: Indications, Access, Substrates, and Compounding 13.2 Refeeding Syndrome and Complications of Parenteral Nutrition 13.3 Nutrition Counseling and Behavior Change Theories
14 Chapter 14: Nutrition Updates: Supplements, Diet Trends, and Sports Nutrition
14.1 Dietary Supplements, Herbal Medicines, and Functional Foods 14.2 Vegetarian Diets, Protein Complementation, and Popular Diet Trends 14.3 Sports Nutrition and Workplace Wellness Programs
15 Chapter 15: Community Nutrition and Population Assessment
15.1 Community Nutrition Principles, the ND's Roles, and the Philippine Health Delivery System 15.2 Nutritional Epidemiology and Health Status Indicators in the Philippines 15.3 Assessment of Community Nutritional Status and Operation Timbang Plus (OPT+)
16 Chapter 16: Dietary Surveys, Nutrition Research, and Surveillance
16.1 Food Consumption Surveys, Biochemical Tests in Surveys, and Clinical Signs of Deficiency 16.2 Food and Nutrition Research Methods, Sampling, Sample Size, and Research Ethics 16.3 National Nutrition Surveys, Demographic Data, and Designing a Nutrition Surveillance System
17 Chapter 17: Nutrition Education and Program Evaluation
17.1 Nutrition Education: Definition, Principles of Learning, Methods, and Teaching Aids 17.2 Designing a Nutrition Education Program and Measuring Customer Satisfaction 17.3 Program Planning Cycle, SMART Objectives, and Types of Evaluation
18 Chapter 18: Program Planning, Interventions, and Food Security
18.1 Nutrition Program Planning: Needs, Priorities, Constraints, Goals, and Using Evaluation Results 18.2 Nutrition Interventions and Programs for Specific Population Groups 18.3 Food and Nutrition Security, Dietary Diversity, and Vulnerable Populations
19 Chapter 19: Nutrition Governance, Networking, and Program History
19.1 National Nutrition Council (NNC) Structure and Philippine Plan of Action for Nutrition (PPAN) 19.2 Nutrition Agencies, Networking, Community Linkages, Teamwork, and Nutrition Legislation 19.3 Development of Philippine Nutrition Programs and the Country's Nutrition Problems
20 Chapter 20: Fortification, Feeding, and First 1,000 Days Laws
20.1 Food Fortification (RA 8976), Salt Iodization (RA 8172), and the 2024 Salt Industry Law 20.2 Supplementary Feeding Programs (RA 11037) and DSWD/DepEd Interventions 20.3 First 1,000 Days Law (RA 11148) and Maternal-Child Interventions
21 Chapter 21: Nutrition in the Life Cycle I
21.1 Infant and Young Child Feeding (IYCF), Philippine Milk Code (EO 51), and RA 10028 21.2 Nutrition in Pregnancy and Lactation: Physiology, Needs, Meal Patterns, and Problems 21.3 Nutrition from Infancy to School Age: Growth, Feeding Patterns, Problems, and School Programs
22 Chapter 22: Nutrition in the Life Cycle II
22.1 Nutrition for Adolescents and Adults: Growth Spurt, Risk Factors, and NCD Prevention 22.2 Nutrition for Older Adults: Aging Changes, Needs, Problems, and Senior Citizen Programs
23 Chapter 23: Food Science and Plant Foods
23.1 Chemistry of Starches, Proteins, Lipids, and Emulsions in Cooking 23.2 Food Pigments, Flavor Chemistry, and Browning Reactions (Maillard & Enzymatic) 23.3 Fruits, Vegetables, and Legumes: Classification, Market Forms, Quality, Storage, and Cookery
24 Chapter 24: Animal Foods, Cereals and Baking, and Cooking Methods
24.1 Meat, Poultry, Fish, Eggs, and Milk: Structure, Quality, Storage, and Cookery 24.2 Cereals, Flour Mixtures and Baking, Sugar Cookery, Fats and Oils, and Beverages 24.3 Heat Transfer, Dry-Heat and Moist-Heat Cooking Methods, and Filipino Cooking Techniques
25 Chapter 25: Culinary Skills, Family Meal Planning, and Food Quality
25.1 Culinary Vocabulary, Knife Cuts, Basic Sauces, and Accurate Measurement 25.2 Meal Planning for the Family, Food Budgeting, and Recipe Development 25.3 Sensory Evaluation, Objective Food Tests, and Quality Assurance in Food Production
26 Chapter 26: Food Microbiology, Preservation, and Food Law
26.1 Foodborne Pathogens, Microbial Kinetics, and FAT TOM Parameters 26.2 Food Preservation Methods, Thermal Processing, and Packaging 26.3 Philippine Food Laws, Regulatory Agencies, and Food Labeling
27 Chapter 27: Sanitation, HACCP, Waste, and Workplace Safety
27.1 Sanitation Standard Operating Procedures (SSOP) and Good Manufacturing Practices (GMP) 27.2 HACCP Principles and Critical Control Point Management in Food Service 27.3 Waste Management, Pest Control Regulation, and Occupational Safety in Food Service
28 Chapter 28: Food Service Systems, Production Planning, and Menus
28.1 Types of Food Service Delivery Systems (Conventional, Ready-Prepared, Commissary, Assembly) 28.2 Forecasting, Production Planning, and Quantity Food Production Techniques 28.3 Institutional Menu Planning, Modified Diets, and Recipe Standardization
29 Chapter 29: Distribution, Purchasing, and Storage
29.1 Food Distribution and Service Systems in Hospitals and Other Institutions 29.2 Food Purchasing Methods, Specifications, and Receiving 29.3 Storage Management, Inventory Control, and Valuation
30 Chapter 30: Cost Control, Financial Management, and Facility Layout
30.1 Food Cost Accounting, Yield Testing, and Portion Control Formulas 30.2 Menu Pricing Models, Break-Even Analysis, and Financial Statements 30.3 Food Service Facility Layout, Equipment Selection, and Workflow Ergonomics
31 Chapter 31: Equipment, Management, and Human Resources
31.1 Food Service Equipment: Selection, Capacity, Life-Cycle Cost, Depreciation, and Maintenance 31.2 Management Functions, Theories, Leadership Styles, and Managing Change in Food Service 31.3 Human Resource Management: Job Design, Recruitment, Training, Appraisal, and Discipline
32 Chapter 32: Labor Law, Permits, and Food Service Marketing
32.1 Philippine Labor Laws and Business Permits for Food Service Operations 32.2 Food Service Marketing, Menu Engineering, and Sustainable Food Service
6.3 ABCD Methods of Clinical Nutrition Assessment
Key Takeaways Explain This Topic AI
The Asia-Pacific BMI classification defines overweight at ≥ 23.0 kg/m 2 \ge 23.0\text{ kg/m}^2 ≥ 23.0 kg/m 2 and obesity at ≥ 25.0 kg/m 2 \ge 25.0\text{ kg/m}^2 ≥ 25.0 kg/m 2 to reflect increased visceral adiposity and cardiometabolic risk in Filipino populations at lower BMI thresholds than WHO international criteria.
Tannhauser's method calculates Ideal Body Weight (IBW) as [ Height (cm) − 100 ] − 10 % [\text{Height (cm)} - 100] - 10\% [ Height (cm) − 100 ] − 10% , providing the clinical standard for establishing Desirable Body Weight (%DBW) across Philippine hospital diet manuals.
Serum albumin (half-life 18–20 days) and prealbumin (half-life 2 days) function as negative acute-phase reactants that reflect systemic inflammation and physiological stress rather than acute changes in nutritional protein stores.
The Nutrition-Focused Physical Exam (NFPE) detects bilateral muscle wasting, subcutaneous fat depletion, and microvascular deficiency signs such as temporal hollowing, Bitot's spots (vitamin A), and koilonychia (iron).
Last updated: October 2026
Clinical nutrition assessment is the systematic, iterative method of obtaining, verifying, and interpreting data needed to identify nutrition-related problems, their causes, and their clinical significance. As the foundational first step of the Nutrition Care Process (NCP) , assessment provides the empirical justification for all downstream diagnostic, therapeutic, and monitoring actions. In clinical dietetics, assessment is organized into four core pillars: Anthropometric measurements (A) , Biochemical and laboratory markers (B) , Clinical and physical examination findings (C) , and Dietary evaluation (D) .
Anthropometric Assessment: Body Dimensions, Composition, and Weight Dynamics
Anthropometry measures the physical dimensions and gross composition of the human body. When performed with calibrated equipment and standardized protocols, anthropometric data detect protein-energy malnutrition, track somatic tissue accretion or wasting, and quantify central adiposity.
Stature and Body Weight Protocols
Height / Stature: Measured to the nearest 0.1 cm 0.1\text{ cm} 0.1 cm using a wall-mounted stadiometer with the patient in the Frankfurt horizontal plane (head, scapulae, buttocks, and heels aligned against the vertical board). For bedridden, kyphotic, or contractured adult patients, knee height measured with a sliding caliper provides an objective alternative using the Chumlea equations : Men Stature (cm) = [ 2.02 × Knee Height (cm) ] − [ 0.24 × Age (yr) ] + 64.19 \text{Men Stature (cm)} = [2.02 \times \text{Knee Height (cm)}] - [0.24 \times \text{Age (yr)}] + 64.19 Men Stature (cm) = [ 2.02 × Knee Height (cm) ] − [ 0.24 × Age (yr) ] + 64.19 Women Stature (cm) = [ 1.83 × Knee Height (cm) ] − [ 0.24 × Age (yr) ] + 84.88 \text{Women Stature (cm)} = [1.83 \times \text{Knee Height (cm)}] - [0.24 \times \text{Age (yr)}] + 84.88 Women Stature (cm) = [ 1.83 × Knee Height (cm) ] − [ 0.24 × Age (yr) ] + 84.88 Alternatively, total arm span (distance between the tips of the middle fingers with arms extended horizontally at 90 ∘ 90^\circ 9 0 ∘ ) directly correlates with peak adult stature.
Weight: Measured to the nearest 0.1 kg 0.1\text{ kg} 0.1 kg using a calibrated mechanical beam balance or medical-grade digital scale after voiding and in light indoor clothing. In bedridden patients, calibrated bed scales or sling scales are mandatory.
Body Mass Index (BMI): WHO International vs. Asia-Pacific Standards
Body Mass Index (BMI, Quetelet's index) expresses weight adjusted for stature: BMI = Weight (kg) [ Height (m) ] 2 \text{BMI} = \frac{\text{Weight (kg)}}{[\text{Height (m)}]^2} BMI = [ Height (m) ] 2 Weight (kg)
While the World Health Organization (WHO) international classification defines overweight at ≥ 25.0 kg/m 2 \ge 25.0\text{ kg/m}^2 ≥ 25.0 kg/m 2 and obesity at ≥ 30.0 kg/m 2 \ge 30.0\text{ kg/m}^2 ≥ 30.0 kg/m 2 , epidemiologic research across Asian populations demonstrates that Asians exhibit a higher body fat percentage, greater abdominal visceral adiposity, and elevated cardiometabolic risk at substantially lower BMIs. Consequently, the WHO Western Pacific Region (WPRO) , with the International Association for the Study of Obesity and the International Obesity Task Force, proposed the Asia-Pacific BMI classification (2000), which many Philippine clinical guidelines use. FNRI's national surveys report adult overweight and obesity using the WHO international cut-off of BMI 25 and above, so always check which standard a question uses:
Classification WHO International Criteria ( kg/m 2 \text{kg/m}^2 kg/m 2 ) Asia-Pacific / Philippine Cutoffs ( kg/m 2 \text{kg/m}^2 kg/m 2 ) Cardiometabolic Risk Profile
Underweight < 18.5 < 18.5 < 18.5 < 18.5 < 18.5 < 18.5 Increased risk of infectious complications and micronutrient deficiency
Normal / Desirable 18.5 − 24.9 18.5 - 24.9 18.5 − 24.9 18.5 − 22.9 18.5 - 22.9 18.5 − 22.9 Lowest clinical morbidity and mortality
Overweight (At Risk) 25.0 − 29.9 25.0 - 29.9 25.0 − 29.9 23.0 − 24.9 23.0 - 24.9 23.0 − 24.9 Increased risk of Type 2 diabetes, dyslipidemia, and hypertension
Obese Class I 30.0 − 34.9 30.0 - 34.9 30.0 − 34.9 25.0 − 29.9 25.0 - 29.9 25.0 − 29.9 Moderate risk of coronary artery disease and metabolic syndrome
Obese Class II ≥ 35.0 \ge 35.0 ≥ 35.0 ≥ 30.0 \ge 30.0 ≥ 30.0 Severe / high risk of cardiovascular disease, stroke, and early mortality
Important
Always check which classification a question names. Asia-Pacific cut-offs are Normal 18.5 – 22.9 kg/m 2 18.5–22.9\text{ kg/m}^2 18.5–22.9 kg/m 2 , Overweight (at risk) 23.0 – 24.9 kg/m 2 23.0–24.9\text{ kg/m}^2 23.0–24.9 kg/m 2 , and Obese ≥ 25.0 kg/m 2 \ge 25.0\text{ kg/m}^2 ≥ 25.0 kg/m 2 . The WHO international cut-offs used in FNRI survey reports are Overweight 25.0 – 29.9 kg/m 2 25.0–29.9\text{ kg/m}^2 25.0–29.9 kg/m 2 and Obese ≥ 30.0 kg/m 2 \ge 30.0\text{ kg/m}^2 ≥ 30.0 kg/m 2 .
Ideal Body Weight (IBW) / Desirable Body Weight (DBW) Formulations
Tannhauser Method (Standard Philippine Clinical Practice): Widely utilized across Philippine hospital dietetics and the Nutritionist-Dietitians' Association of the Philippines (NDAP) diet manuals: IBW (kg) = [ Height in cm − 100 ] − 10 % \text{IBW (kg)} = [\text{Height in cm} - 100] - 10\% IBW (kg) = [ Height in cm − 100 ] − 10% Worked Example: A Filipino male patient with a height of 5 ’ 7 " 5\text{' }7\text{"} 5 ’ 7 " ( 170.2 cm ≈ 170 cm 170.2\text{ cm} \approx 170\text{ cm} 170.2 cm ≈ 170 cm ): 170 − 100 = 70 kg 170 - 100 = 70\text{ kg} 170 − 100 = 70 kg 70 − ( 70 × 0.10 ) = 70 − 7 = 63 kg (IBW) 70 - (70 \times 0.10) = 70 - 7 = 63\text{ kg (IBW)} 70 − ( 70 × 0.10 ) = 70 − 7 = 63 kg (IBW)
Hamwi Method (Rule of Thumb):
Adult Males: 106 lbs 106\text{ lbs} 106 lbs for the first 5 feet 5\text{ feet} 5 feet ( 60 inches 60\text{ inches} 60 inches ) + 6 lbs + 6\text{ lbs} + 6 lbs for each additional inch over 5 feet 5\text{ feet} 5 feet .
Adult Females: 100 lbs 100\text{ lbs} 100 lbs for the first 5 feet 5\text{ feet} 5 feet ( 60 inches 60\text{ inches} 60 inches ) + 5 lbs + 5\text{ lbs} + 5 lbs for each additional inch over 5 feet 5\text{ feet} 5 feet .
Frame Adjustments: Subtract 10 % 10\% 10% for a small frame; add 10 % 10\% 10% for a large frame.
Amputation Corrections: Adjust target IBW based on lost anatomical segment percentages: entire lower limb ( 16.0 % 16.0\% 16.0% ), lower leg without foot ( 4.4 % 4.4\% 4.4% ), entire arm ( 5.0 % 5.0\% 5.0% ), forearm with hand ( 2.3 % 2.3\% 2.3% ), foot ( 1.5 % 1.5\% 1.5% ), hand ( 0.7 % 0.7\% 0.7% ).
Weight Proportionality Indices
Percentage Desirable Body Weight (%DBW): % DBW = ( Actual Body Weight IBW ) × 100 \%\text{DBW} = \left(\frac{\text{Actual Body Weight}}{\text{IBW}}\right) \times 100 % DBW = ( IBW Actual Body Weight ) × 100
- ≥ 120 % \ge 120\% ≥ 120% : Obese
- 110 − 119 % 110 - 119\% 110 − 119% : Overweight
- 90 − 109 % 90 - 109\% 90 − 109% : Desirable / Normal
- 80 − 89 % 80 - 89\% 80 − 89% : Mild malnutrition
- 70 − 79 % 70 - 79\% 70 − 79% : Moderate malnutrition
- < 70 % < 70\% < 70% : Severe malnutrition
Percentage Usual Body Weight (%UBW): Evaluates deviation from a patient's individual physiological baseline: % UBW = ( Actual Body Weight Usual Body Weight ) × 100 \%\text{UBW} = \left(\frac{\text{Actual Body Weight}}{\text{Usual Body Weight}}\right) \times 100 % UBW = ( Usual Body Weight Actual Body Weight ) × 100
- 85 − 95 % 85 - 95\% 85 − 95% : Mild malnutrition
- 75 − 84 % 75 - 84\% 75 − 84% : Moderate malnutrition
- < 75 % < 75\% < 75% : Severe malnutrition
Percentage Weight Loss Over Time (Blackburn Formula): Quantifies velocity of somatic tissue wasting: % Weight Loss = ( Usual Weight − Actual Weight Usual Weight ) × 100 \%\text{Weight Loss} = \left(\frac{\text{Usual Weight} - \text{Actual Weight}}{\text{Usual Weight}}\right) \times 100 % Weight Loss = ( Usual Weight Usual Weight − Actual Weight ) × 100
- Time Frame Significant Weight Loss Severe Weight Loss
- 1 Week 1 − 2 % 1 - 2\% 1 − 2% > 2 % > 2\% > 2%
- 1 Month 5 % 5\% 5% > 5 % > 5\% > 5%
- 3 Months 7.5 % 7.5\% 7.5% > 7.5 % > 7.5\% > 7.5%
- 6 Months 10 % 10\% 10% > 10 % > 10\% > 10%
- Somatic Reserves and Regional Fat Distribution
Mid-Upper Arm Circumference (MUAC): Assesses combined skeletal muscle and subcutaneous adipose tissue. In pediatric crisis triage, MUAC < 11.5 cm < 11.5\text{ cm} < 11.5 cm ( 115 mm 115\text{ mm} 115 mm ) indicates Severe Acute Malnutrition (SAM).
Mid-Arm Muscle Circumference (MAMC): Derived by eliminating triceps skinfold (TSF) fat thickness: MAMC (cm) = MUAC (cm) − [ 0.314 × TSF (mm) ] \text{MAMC (cm)} = \text{MUAC (cm)} - [0.314 \times \text{TSF (mm)}] MAMC (cm) = MUAC (cm) − [ 0.314 × TSF (mm) ]
Calf Circumference (CC): The Mini Nutritional Assessment scores CC < 31 cm < 31\text{ cm} < 31 cm as low; the Asian Working Group for Sarcopenia (AWGS 2019) uses CC < 34 cm < 34\text{ cm} < 34 cm in men and < 33 cm < 33\text{ cm} < 33 cm in women to case-find possible sarcopenia.
Waist Circumference (WC) and Waist-to-Hip Ratio (WHR): Central obesity markers reflecting visceral fat deposits. Asian cutoffs:
Waist Circumference: Men ≥ 90 cm \ge 90\text{ cm} ≥ 90 cm ( 35.4 in 35.4\text{ in} 35.4 in ); Women ≥ 80 cm \ge 80\text{ cm} ≥ 80 cm ( 31.5 in 31.5\text{ in} 31.5 in ).
Waist-to-Hip Ratio: Men > 0.90 > 0.90 > 0.90 ; Women > 0.85 > 0.85 > 0.85 indicate android adiposity and elevated cardiovascular risk.
Biochemical Data: Laboratory Biomarkers and Metabolic Panels
Biochemical tests provide objective data regarding organ function, fluid and electrolyte balance, and metabolic stress. However, nutritional interpretations must account for non-nutritional confounders, hydration shifts, and the systemic inflammatory cascade.
Visceral Protein Dynamics & The Inflammatory Trap
For decades, serum visceral proteins were misconstrued as direct measures of total body protein mass. Modern clinical science demonstrates that visceral proteins function as negative acute-phase reactants controlled by hepatic cytokine signaling:
Biomarker Reference Range Biological Half-Life Clinical Strengths & Limitations
Serum Albumin 3.5 − 5.0 g/dL 3.5 - 5.0\text{ g/dL} 3.5 − 5.0 g/dL 18 − 20 days 18 - 20\text{ days} 18 − 20 days Large body pool ( 300 − 500 g 300 - 500\text{ g} 300 − 500 g ). Insensitive to acute dietary changes. Synthesis down-regulated by IL-1, IL-6, and TNF- α \alpha α . Levels decline during fluid overload, nephrotic syndrome, liver failure, and severe burns. Primary utility: marker of systemic disease severity, surgical risk, and systemic inflammation.
Prealbumin (Transthyretin) 15 − 36 mg/dL 15 - 36\text{ mg/dL} 15 − 36 mg/dL 2 days 2\text{ days} 2 days Small pool ( 10 g 10\text{ g} 10 g ). Rapid response to initiation of nutritional support and calorie-protein repletion. Down-regulated in acute inflammation/infection; falsely elevated in severe renal failure due to impaired renal clearance.
Transferrin 200 − 400 mg/dL 200 - 400\text{ mg/dL} 200 − 400 mg/dL 8 − 10 days 8 - 10\text{ days} 8 − 10 days Intermediate half-life. Synthesized in hepatocytes. Falsely elevated in iron deficiency anemia; suppressed in protein-wasting nephropathies, liver disease, and sepsis.
C-Reactive Protein (CRP) < 1.0 mg/L < 1.0\text{ mg/L} < 1.0 mg/L ( < 10 mg/L < 10\text{ mg/L} < 10 mg/L in acute phase) 19 hours 19\text{ hours} 19 hours Positive acute-phase reactant . Rises sharply within 4–6 hours of tissue injury, infection, or surgical stress. Diagnostic rule: An albumin or prealbumin level measured when CRP is elevated reflects systemic inflammatory suppression rather than pure malnutrition.
Note
A patient with acute thermal burns and an albumin of 2.0 g/dL 2.0\text{ g/dL} 2.0 g/dL cannot be diagnosed with chronic protein-energy malnutrition solely based on laboratory values. Increased transcapillary escape and hepatic reprioritization toward positive acute-phase reactants (CRP, fibrinogen) drive acute hypoalbuminemia.
Nitrogen Balance Assessment
Nitrogen balance evaluates somatic protein catabolism versus protein accretion: Nitrogen Balance (g/day) = ( 24-hr Protein Intake (g) 6.25 ) − [ 24-hr Urine Urea Nitrogen (UUN in g) + 4 ] \text{Nitrogen Balance (g/day)} = \left(\frac{\text{24-hr Protein Intake (g)}}{6.25}\right) - [\text{24-hr Urine Urea Nitrogen (UUN in g)} + 4] Nitrogen Balance (g/day) = ( 6.25 24-hr Protein Intake (g) ) − [ 24-hr Urine Urea Nitrogen (UUN in g) + 4 ]
The factor 6.25 6.25 6.25 accounts for the average 16 % 16\% 16% nitrogen content of dietary protein ( 100 / 16 = 6.25 100 / 16 = 6.25 100/16 = 6.25 ).
The constant + 4 +4 + 4 accounts for insensible losses via skin, sweat, and unmeasured fecal nitrogen excretion.
Clinical Interpretation: Balance of 0 0 0 indicates protein equilibrium; negative balance indicates active catabolism; positive balance ( + 2 to + 4 g N/day +2\text{ to }+4\text{ g N/day} + 2 to + 4 g N/day ) indicates anabolic tissue recovery.
Metabolic, Renal, and Glycemic Panels
Total Lymphocyte Count (TLC): TLC = [ % Lymphocytes × WBC ] / 100 \text{TLC} = [\%\text{Lymphocytes} \times \text{WBC}] / 100 TLC = [ % Lymphocytes × WBC ] /100 . Depletion thresholds: Mild ( 1500 − 1999 cells/mm 3 1500 - 1999\text{ cells/mm}^3 1500 − 1999 cells/mm 3 ), Moderate ( 800 − 1499 cells/mm 3 800 - 1499\text{ cells/mm}^3 800 − 1499 cells/mm 3 ), Severe ( < 800 cells/mm 3 < 800\text{ cells/mm}^3 < 800 cells/mm 3 ). Heavily confounded by corticosteroid therapy, chemotherapy, and viral infections.
Renal Panel: BUN ( 7 − 20 mg/dL 7 - 20\text{ mg/dL} 7 − 20 mg/dL ), Serum Creatinine ( 0.6 − 1.2 mg/dL 0.6 - 1.2\text{ mg/dL} 0.6 − 1.2 mg/dL ). A BUN : Creatinine \text{BUN}:\text{Creatinine} BUN : Creatinine ratio > 20 : 1 > 20:1 > 20 : 1 indicates prerenal azotemia or hypovolemic dehydration; a ratio of 10 − 15 : 1 10 - 15:1 10 − 15 : 1 suggests intrinsic renal disease.
Glycemic Control: Fasting Blood Glucose ( 70 − 99 mg/dL 70 - 99\text{ mg/dL} 70 − 99 mg/dL normal; 100 − 125 mg/dL 100 - 125\text{ mg/dL} 100 − 125 mg/dL prediabetes; ≥ 126 mg/dL \ge 126\text{ mg/dL} ≥ 126 mg/dL diabetes). HbA1c \text{HbA1c} HbA1c ( < 5.7 % < 5.7\% < 5.7% normal; 5.7 − 6.4 % 5.7 - 6.4\% 5.7 − 6.4% prediabetes; ≥ 6.5 % \ge 6.5\% ≥ 6.5% diabetes).
Clinical and Physical Examination: The Nutrition-Focused Physical Exam (NFPE)
The Nutrition-Focused Physical Exam (NFPE) is a hands-on, head-to-toe clinical evaluation that detects loss of subcutaneous adipose reserves, bilateral somatic muscle wasting, fluid accumulation, and nutrient-specific clinical pathologies.
Systematic NFPE Anatomic Assessment
Subcutaneous Fat Loss: Evaluated via inspection and gentle palpation:
Orbital Region: Loss of orbital fat pads produces hollow, sunken eyes with dark concentric circles.
Buccal Region: Concavity over the cheekbones indicates severe adipose depletion.
Triceps / Thoracic Region: Pinching skinfold over the mid-triceps reveals minimal tissue separation between thumb and index finger; ribs become visibly prominent with deep intercostal depressions.
Somatic Muscle Wasting: Evaluated bilaterally for volume and tone:
Temporalis Muscle: Scooped-out, hollow temples when viewing the patient from the front.
Clavicular Region: Pectoralis major and deltoid wasting creates protruding clavicles with visible supraclavicular and infraclavicular depressions.
Scapular Region: Prominent scapular spine, winged scapulae, and depressions over supraspinatus/infraspinatus muscles.
Dorsal Interosseous Muscles: Depression in the web space between thumb and index finger when the patient pinches their fingertips together.
Quadriceps and Gastrocnemius: Femoral condyles become prominent; calves appear thin, flaccid, and loose.
Fluid Accumulation and Edema Grading: Pitting edema is assessed over bony prominences (pretibial, medial malleolus, sacrum) by applying firm thumb pressure for 5 seconds:
1+ (Mild): 2 mm 2\text{ mm} 2 mm depression, disappears almost instantly.
2+ (Moderate): 4 mm 4\text{ mm} 4 mm depression, disappears in 10 − 15 seconds 10 - 15\text{ seconds} 10 − 15 seconds .
3+ (Severe): 6 mm 6\text{ mm} 6 mm deep pit, persists for > 1 minute > 1\text{ minute} > 1 minute ; extremity appears visibly swollen.
4+ (Very Severe): 8 mm 8\text{ mm} 8 mm very deep pit, persists for 2 − 5 minutes 2 - 5\text{ minutes} 2 − 5 minutes ; gross distortion of tissue architecture.
Warning
Edema and ascites mask profound somatic muscle and fat wasting on the scale. An RND must never evaluate weight trends in isolation when fluid retention is clinically evident.
Clinical Signs of Micronutrient Deficiencies
- Anatomic Site Physical Finding Primary Nutritional Etiology
- Hair Corkscrew hair, coiled appearance, perifollicular hemorrhages Vitamin C (Ascorbic acid)
- Hair Dull, dry, depigmented hair with easy pluckability; "flag sign" Severe protein malnutrition
- Eyes Bitot's spots (foamy keratin plaques on bulbar conjunctiva), xerophthalmia Vitamin A (Retinol)
- Eyes Pale conjunctiva Iron deficiency anemia
Lips / Mouth Angular cheilosis, stomatitis, vertical fissuring Riboflavin ( B 2 B_2 B 2 ), Pyridoxine ( B 6 B_6 B 6 ), Niacin ( B 3 B_3 B 3 ), Iron
Tongue Beefy red, smooth, atrophic tongue (glossitis) Vitamin B 12 B_{12} B 12 (Cobalamin), Folate, Niacin, Iron
- Tongue Magenta-colored tongue Riboflavin ( B 2 B_2 B 2 )
- Gums Spongy, swollen, bleeding gums with loose teeth Vitamin C (Scurvy)
- Skin Symmetrical photosensitive dermatitis, scaling, "Casal's necklace" Niacin ( B 3 B_3 B 3 , Pellagra)
- Skin Follicular hyperkeratosis (phrynoderma, gooseflesh texture) Vitamin A, essential fatty acids
- Skin Petechiae, purpura, ecchymoses Vitamin C, Vitamin K
- Skin Impaired wound healing, acro-orificial erythematous rash Zinc deficiency, protein depletion
- Nails Koilonychia (concave spoon-shaped nails) Chronic severe iron deficiency
Nails Muehrcke's lines (transverse white bands) Severe hypoalbuminemia ( < 2.0 g/dL < 2.0\text{ g/dL} < 2.0 g/dL )
- Thyroid Diffuse thyroid enlargement (goiter) Iodine deficiency
- Dietary Assessment Methods & Nutritional Screening Tools
Dietary assessment evaluates quantitative nutrient intake, eating behaviors, meal schedules, and socioeconomic constraints.
Retrospective vs. Prospective Assessment Methods
24-Hour Food Recall: Retrospective interview utilizing the USDA Automated Multiple-Pass Method :
Pass 1 (Quick List): Uninterrupted listing of all foods/beverages consumed.
Pass 2 (Forgotten Foods Probe): Specific inquiries into beverages, condiments, snacks, alcohol, and sweets.
Pass 3 (Time & Occasion): Contextual timing, meal location, and social setting.
Pass 4 (Detail & Portion Size): Food preparation methods, brand names, and standardized portion models.
Pass 5 (Final Review): Comprehensive check for omitted items.
Pros/Cons: Low patient burden, high compliance; relies on memory, subject to underreporting, and does not capture habitual seasonal variation.
Food Frequency Questionnaire (FFQ): Predefined checklist quantifying frequency (daily, weekly, monthly) of food categories over a reference period (past month or year). Excellent for large-scale epidemiological studies; limited precision for individual clinical calorie-protein calculations.
Food Diary / Weighed Food Records: Prospective documentation over 3 to 7 consecutive days (including at least one weekend day) where the client weighs or measures all food items prior to consumption. Considered the gold standard for outpatient research; high respondent burden, requires literacy, and frequently causes dietary reactivity (eating less or simpler foods to simplify logging).
Diet History: Comprehensive clinical interview evaluating long-term dietary patterns, cultural food beliefs, gastrointestinal symptoms, appetite shifts, food allergies, and cooking resources.
Validated Clinical Screening Tools
Hospital accreditation standards commonly require nutritional screening within 24 hours of hospital admission to identify individuals requiring full dietetic consultation:
Subjective Global Assessment (SGA): Validated clinical instrument integrating medical history (weight change over past 6 months, dietary intake change, gastrointestinal symptoms persisting > 2 weeks > 2\text{ weeks} > 2 weeks , functional capacity/bed rest, metabolic stress of disease) with physical exam (loss of subcutaneous fat, temporal/clavicular muscle wasting, edema, ascites). Categorizes patients into:
- SGA-A: Well-nourished
- SGA-B: Moderately malnourished or suspected of malnutrition
- SGA-C: Severely malnourished
Malnutrition Universal Screening Tool (MUST): Evaluates three clinical criteria: current BMI score ( 0 − 2 0 - 2 0 − 2 ), unexplained weight loss in prior 3–6 months ( 0 − 2 0 - 2 0 − 2 ), and acute disease effect causing nil per os for > 5 days > 5\text{ days} > 5 days ( + 2 +2 + 2 ). Score ≥ 2 \ge 2 ≥ 2 signifies high malnutrition risk.
Nutritional Risk Screening 2002 (NRS-2002): Inpatient screening tool evaluating impaired nutritional status score ( 0 − 3 0 - 3 0 − 3 ), disease severity score ( 0 − 3 0 - 3 0 − 3 ), and age adjustment ( + 1 +1 + 1 if age ≥ 70 years \ge 70\text{ years} ≥ 70 years ). A total score ≥ 3 \ge 3 ≥ 3 indicates nutritional risk requiring immediate medical nutrition therapy.